Growth and social-environmental impact co-exist. We have a triple-purpose playbook
- For more information BankaBio
Notice & Outcomes
FY 2019-20
- AGM Notice FY 2019-20
- AGM_FY_2019-20-Voting_Results_and_Scrutinizer’s_Report
- Postal Ballot Form
- Postal Ballot Notice
- Postal_Ballot-Voting_Results_and_Scrutinizers_Report
- Resolutions_Passed_through_Postal_Ballot
FY 2020-21
- Notice of Board Meeting 29th June 2020
- Notice of Board Meeting on 12 Feb 2021
- Notice of Board Meeting on 13 Nov 2021
FY 2021-22
Annual General Meeting
Board Meeting
Extraordinary General Meeting
- Corrigendum_Notice_of_EGM_2021-22
- Notice_of_EGM_2021-22
- Proceedings_of_EGM_(20_March_2022)
- Scrutiniser_Report_-_EGM_(20_March_2022)
- Voting_Results_-_EGM_(20_March_2022)
Unclaimed Dividend
FY 2022-23
Annual General Meeting
Board meeting
- Board Meeting Outcome – 27 Feb 2023
- Board Meeting Notice – 27 Feb 2023
- Board Meeting Outcome – 13 February 2023
- Board Meeting_Notice 13-Feb-2023
- NSE Intimation BM Outcome 14 November 2022
- NSE Intimation – Board Meeting on 14 Nov 2022
- Board Meeting Outcome 2-Sep-2022
- Board Meeting Outcome 10-Aug-2022
- Board Meeting Outcome 30-May-2022
- Board Meeting_Notice 2-Sep-2022
- Board Meeting_Notice 10-Aug-2022
- Board Meeting_Notice 30-May-2022
FY 2023-24
Annual General Meeting
- Notice of 11th AGM – 25 September 2023
- Outcome of 11th AGM – 25 September 2023
- Voting Results and Scrutiniser Report of 11th AGM – 25 September 2023
Board meeting
- Board Meeting_Outcome_25 August 2023
- Board Meeting_Notice_25 August 2023
- Board Meeting Outcome_10 August 2023
- Board Meeting Notice_10 August 2023
- Board Meeting Outcome_30 May 2023
- Board Meeting Notice_30 May 2023
Financial Results
FY 2020-21
- Financial_Results_Q2_and_Annual_2020-21
- Financial_Results_Q3_and_Annual_2020-21
- Financial_Results_Q4_and_Annual_2020-21
FY 2021-22
- Financial_Results_Q1_and_Annual_2021-22
- Financial_Results_Q2_and_Annual_2021-22
- Financial_Results_Q3_and_Annual_2021-22
- Financial_Results_Q4_and_Annual_2021-22
FY 2022-23
- Financial_Results_Q4_FY_2022-23
- Financial_Results_Q3_FY_2022-23
- Financial_Results_Q2_FY_2022-23
- Financial_Results_Q1_FY_2022-23
FY 2023-24
Annual Reports
FY 2019-20
FY 2020-21
FY 2022-23
- ShareHolding Pattern 31-March-2023
- ShareHolding Pattern 31-Dec-2022
- ShareHolding Pattern 30-Sept-2022
- ShareHolding Pattern 30-June-2022
FY 2023-24
FY 2019-20
FY 2020-21
FY 2022-23
- Paper Advertisement – Financial Results – March 2022
- Paper Advertisement – Financial Results – Dec 2022
- Paper Advertisement – Financial Results – June 2022
- Paper Advertisement – Financial Results – March 2022
- Paper Advertisement – Financial Results – Sept 2022
- Paper Advertisement – Notice of 10th AGM
- Paper Advertisement – Notice of 10th AGM_Post dispatch
- Paper Advertisement – Voting Results of 10th AGM
FY 2023-24
- Corporate Governance Report – 30 June 2023
- Annual Secretarial Compliance Report 31 March 2023
- Corporate Governance Report – 31 March 2023
- Corporate Governance Report – 31 Dec 2022
- Corporate Governance Report – Half Year 30.09.2022
- Annual Secretarial Compliance Report 31Mar2021
- Chartered_Accountant_Certificate – Preferntial Issue
- Corporate Governance Report – 31 March 2021
- Practicing_Company_Secretary_Certificate – Preferential Issue
- Mr. T V Rama Krishna
Chief Financial Officer & Executive Director - Ms. Archana Arigela
Company Secretary and Compliance Officer - Email ID: cs@bankabio.com
Contact Number: 86888 25013
Acquisition
Book Closure
Appointment & Reappointment
Closure of trading window
- Intimation of Trading Window Closure – June 2023
- Intimation of Trading Window Closure – March 2023
- Trading Window Closure 31 Dec 2022
- Intimation of Trading Window Closure – July 2022
General updates
- Issuance of ESOP_AGM approval
- 11th AGM Timeline_Intimation
- Issuance of ESOP_BM approval
- Sale of SSAI_Associate Company
- Non-applicability of Regulation 74(5) of SEBI (DP) Regulations, 2018 – June 2023
- Intimation on allotment of NCD – June 2023
- Investor Complaints Report – March 2023
- Non-applicability of Regulation 74(5) of SEBI (DP) Regulations, 2018 – March 2023
- Investor Complaints Report – Dec 2022
- Non-applicability of 74(5) of SEBI (D&P) – Dec 2022
- Non-applicability of Regulation 74(5) of SEBI (DP) Regulations, 2018 – June 2022
- Non-applicability of Regulation 74(5) of SEBI (DP) Regulations, 2018 – March 2022
- Trading Approval for 5,65,462 equity shares
Related Party Transaction
- Anti-Bribery & Anti-Corruption Policy
- Archival Policy
- CSR Policy – CSR Committee
- Data Privacy Policy
- Determining Material Subsidiary Policy
- Diversity of Board of Directors Policy
- Diversity & Inclusion Policy
- Dividend Distribution Policy
- Environmental Social & Governance (ESG) Policy
- Fraud Prevention Policy
- Material Event or Information Policy
- Materiality of Related Party Transactions and Dealing with Related Party Transactions Policy
- Nomination & Remuneration Policy
- PIT and Policy
- Preservation of Documents Policy
- Prevention of Sexual Harassment at Work Place Policy
- Prohibition of Insider Trading and Policy
- Re-investment Policy
- Related Party Policy
- Reward & Recognition Policy
- Whistle Blower Policy
- Code of Conduct for Independent Directors
- Code of Conduct for Vendors and Contractors
- Code of Ethics and Code of Conduct
- Code of Fair Disclosure
- Composition of various committees of Board of Directors
- Criteria for Making Payment to Non-Executive Directors
- Declaration of Climate and Ecological Emergency
- Development and Succession Planning
- Familirization Programs
- FAQs and Guide Book for Shareholders
- Human Rights, Labour Rights and Decent Work Commitment
- Independent Director Appointment Letter
- Occupational Health & Safety – FRP Unit
- Occupational Health & Safety – FSTPs
- Succession Planning-Regulation 17(4)
- Terms of Reference of Stakeholders Relationship Committee
Statutory Committees
-
Statutory Auditors
PRSV & Co. LLP
Chartered Accountants
Firm Reg. No. S200016 -
Registrar
Bigshare Services Pvt Ltd,
# 06, Right Wing, 3rd Floor, Amrutha Ville,
Opp. Yashoda Hospital, Somajiguda,
Rajbhavan Road, Hyderabad - 500082
Investor Grievance Redressal
-
1. Ms. Archana Arigela
Company Secretary and Compliance Officer -
2. Mr. T V Rama Krishna
CFO & Executive Director
-
Investor Contact Details
Email: cs@bankabio.com
Contact: 040 - 29801495
Board of Directors
View »